Invesaro

Stocks ACM Financial statements

Financial statements

AECOM financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data AECOM files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue17,41118,20320,15613,64213,24013,34113,14814,37816,10516,140
Cost of revenue16,76817,52013,39913,03112,53012,54212,30013,43315,02114,923
Gross profit6436844796127107988489451,0841,217
General and administrative115133136148189155147154160158
Operating income3766543933963816306473248271,027
Interest expense110159185184
Interest income6.728.2140.358.662.9
Other non-operating income8.186.6420.614.611.117.614.2-5.32.1-2.5
Pre-tax income126429212249233409551213718916
Income tax-37.97.71-3.4913.545.88913656.1153204
Income from continuing operations196211170295389114506638
Net income to minority interests67.482.160.777.132.629.824.144.85874.4
Net income96.1339136-261-18617331155.3402562
EBITDA7749326606576198068185001,0061,202
EPS, basic0.622.180.86-1.66-1.171.182.210.402.974.24
EPS, diluted0.622.130.84-1.63-1.161.162.180.392.954.21
Shares, basic (weighted)155156159157159147141139136132
Shares, diluted (weighted)156159162160161150143140136133

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents6928028878861,7081,2291,1721,2601,5811,586
Receivables4,5315,1283,3082,8692,9212,6192,3182,5442,7932,497
Other current assets730697585516692739759730638716
Total current assets6,0016,6827,1277,5357,5306,1745,8236,1707,0566,730
Property, plant and equipment645621614406382399428383354416
Lease right-of-use assets652607540447432463
Goodwill5,8245,9935,9213,4773,4843,5023,3813,4193,4803,701
Intangible assets47941532099.676.954.935.617.86.93183
Other non-current assets219150229172160308293219268254
Total assets13,67014,39714,68114,55112,99911,73411,13911,23312,06212,200
Accounts payable1,9112,2502,7262,4112,3582,0902,0272,1912,5602,261
Accrued liabilities2,3852,2462,2671,8782,2502,1742,1812,2882,3862,490
Deferred revenue9318519971,0591,0511,1891,2981,088
Short-term debt36614214398.320.953.848.689.566.966.3
Total current liabilities5,3055,5786,1306,4626,0905,5225,4045,8506,3745,929
Long-term debt3,7023,7023,4843,2182,0412,1582,1572,1132,4502,647
Lease liabilities745679595549511516
Other non-current liabilities403322329266163145136124156211
Total liabilities10,11710,18210,40310,6529,5858,9048,5348,8509,6919,504
Total debt4,1253,8963,6743,3532,0852,2362,2252,2172,5402,744
Paid-in capital3,6053,7343,8463,9544,0354,1164,1574,2424,3474,609
Retained earnings618962948600174-504-702-1,104-1,282-1,225
Other comprehensive income-858-701-703-864-919-900-980-927-883-893
Shareholders' equity3,3673,9964,0933,6913,2932,7122,4772,2122,1842,493
Minority interests186219186209121117129171186204
Total equity3,5524,2154,2783,8993,4142,8302,6052,3842,3702,696
Total liabilities and equity13,67014,39714,68114,55112,99911,73411,13911,23312,06212,200
Shares outstanding154158157157157143139136133132

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income163421197-184-154203335100460636
Depreciation and amortization399279268261237176171176179176
Stock-based compensation73.483.873.163.854.244.738.545.961.561.4
Deferred income tax-110-49.936.7-9811.1-3.221.5-13615332.6
Change in receivables337-433-382
Change in payables16.6292475251-193-250-103170391-334
Cash from operations814697775778330705714696827822
Capital expenditures-191-86.4-113-101-115-136-137-106-120-137
Acquisitions-5.53-103-5.60-18.7-213
Purchases of investments-0.21-23.5-3.22
Sales and maturities of investments11.70.97.1712.412.415.510.25.983.180
Cash from investing-163-203-59.1-1472,037-421-175-138-211-413
Debt issued4,7065,9538,5297,7014,4523,6393,6193,5076,1692,213
Debt repaid-5,200-7,072-8,040-7,985-5,568-2,726-3,657-3,553-5,878-2,259
Stock issued28.230.135.230.426.425.726.732.934.640.1
Share buybacks-25.9-25.1-179-98.2-187-867-473-379-479-388
Dividends paid-63.3-96.2-115-134
Cash from financing-638-386-625-433-1,628-873-588-473-295-404
Exchange rate effect-5.312.76-6.23-3.96-1.195.49-8.310.511.32-3.83
Net change in cash8.2511084.4194738-583-5885.43230.88
Free cash flow623610661677215568577590708685
Interest paid216226272222201256105154177167
Income taxes paid-13.111.5-40.6-2.5-71-114-105-78.4-140-92

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $60.89 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin5.7%Gross profit / revenue.
Operating margin4.1%Operating income / revenue.
EBITDA margin4.6%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin3.4%Pre-tax income / revenue.
Net margin1.9%Net income / revenue.
FCF margin1.3%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin2.4%Cash from operations / revenue.
Effective tax rate18.8%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)13.1%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)2.4%Net income / average total assets.
Return on invested capital (ROIC)13.1%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue0.3%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue1.1%Capital expenditures / revenue.
D&A / revenue0.5%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y0.2%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y7.1%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y4.0%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y12.2%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y12.8%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y11.4%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y24.1%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y16.6%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y21.9%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y19.5%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y13.7%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y14.2%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y39.7%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y21.8%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y42.7%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y24.5%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y-0.7%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y4.8%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y20.0%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-3.2%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y5.9%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y26.1%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y14.1%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y0.2%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-5.4%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y1.1%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y3.1%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-1.3%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-2.3%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-2.2%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-3.7%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.06xCurrent assets / current liabilities.
Quick ratio0.57x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.17x(Cash + short-term investments) / current liabilities.
Debt / equity1.25xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets22.8%Total debt / total assets.
Liabilities / assets80.0%Total liabilities / total assets.
Net debt$1.73BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA2.43xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage3.12xOperating income / interest expense.
Working capital$340.3MCurrent assets - current liabilities.
Goodwill and intangibles / assets32.8%(Goodwill + intangible assets) / total assets.
Tangible book value-$1.75BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.28xRevenue / average total assets.
Fixed asset turnover33.5xRevenue / average property, plant and equipment.
Receivables turnover6.44xRevenue / average receivables.
Days sales outstanding57 days365 x average receivables / revenue.
Days payables60 days365 x average accounts payable / cost of revenue.
FCF conversion70.6%Free cash flow / net income, when net income is positive.
Capex / operating cash flow44.3%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$2.24Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$119.73Revenue / diluted weighted shares.
FCF per share$1.58Free cash flow / diluted weighted shares.
Operating cash flow per share$2.84Cash from operations / diluted weighted shares.
Book value per share$17.04Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$13.59Tangible book value / shares outstanding.
Cash per share$7.87(Cash + short-term investments) / shares outstanding.
Payout ratio52.0%Dividends paid / net income, when net income is positive.
Dividends / FCF73.7%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF340.1%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$7.84BShare price x shares outstanding.
Enterprise value$9.57BMarket cap + total debt - cash - short-term investments.
P/E27.2xMarket cap / net income. Only when net income is positive.
P/S0.51xMarket cap / revenue.
P/B3.57xMarket cap / shareholders' equity. Only when equity is positive.
P/FCF38.5xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF21.4xMarket cap / cash from operations, when positive.
EV/Sales0.62xEnterprise value / revenue.
EV/EBIT15.2xEnterprise value / operating income, when both are positive.
EV/EBITDA13.4xEnterprise value / EBITDA, when both are positive.
EV/FCF47.0xEnterprise value / free cash flow, when both are positive.
FCF yield2.6%Free cash flow / market cap.
Earnings yield3.7%Net income / market cap (the inverse of P/E).
Dividend yield1.9%Dividends paid over the period / market cap.
Shareholder yield10.7%(Dividends paid + share buybacks) / market cap.
PEG1.11xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was AECOM's revenue in fiscal 2025?

AECOM reported revenue of $16.14B for fiscal 2025, 0.2% higher than the year before.

Was AECOM profitable in fiscal 2025?

Yes. Net income was $561.8M, a net margin of 3.5%.

How much free cash flow did AECOM generate in fiscal 2025?

Cash from operations of $821.6M minus capital expenditures of $136.7M left free cash flow of $684.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to AECOM